Improvement in Cardiac Systolic Function and Reduced Prevalence of Metabolic Syndrome after Two Years of Growth Hormone (GH) Treatment in GH-Deficient Adult Survivors of Childhood-Onset Acute Lymphoblastic Leukemia | Zendy

Cecilia Follin | Zendy; Ulf Thilén | Zendy; Bo Åhrén | Zendy; Eva Marie Erfurth | Zendy

Open Access

Improvement in Cardiac Systolic Function and Reduced Prevalence of Metabolic Syndrome after Two Years of Growth Hormone (GH) Treatment in GH-Deficient Adult Survivors of Childhood-Onset Acute Lymphoblastic Leukemia

Author(s) -

Cecilia Follin,

Ulf Thilén,

Bo Åhrén,

Eva Marie Erfurth

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-2298

Subject(s) - medicine , lymphoblastic leukemia , metabolic syndrome , growth hormone , endocrinology , cardiac function curve , hormone , pediatrics , cardiology , leukemia , heart failure , obesity

Survivors of childhood-onset (CO) acute lymphoblastic leukemia (ALL) treated with prophylactic cranial radiotherapy often exhibit GH deficiency (GHD), which is associated with increased prevalence of cardiovascular risk factors and cardiac dysfunction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research